FDA — authorised 16 October 1986
- Application: BLA019640
- Marketing authorisation holder: LILLY
- Local brand name: HUMATROPE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Humatrope on 16 October 1986
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 October 1986; FDA has authorised it.
LILLY holds the US marketing authorisation.